1. Home
  2. TPST vs BDL Comparison

TPST vs BDL Comparison

Compare TPST & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • BDL
  • Stock Information
  • Founded
  • TPST 2011
  • BDL 1959
  • Country
  • TPST United States
  • BDL United States
  • Employees
  • TPST N/A
  • BDL N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • BDL Restaurants
  • Sector
  • TPST Health Care
  • BDL Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • BDL Nasdaq
  • Market Cap
  • TPST 45.5M
  • BDL 52.7M
  • IPO Year
  • TPST N/A
  • BDL N/A
  • Fundamental
  • Price
  • TPST $10.45
  • BDL $31.84
  • Analyst Decision
  • TPST Hold
  • BDL
  • Analyst Count
  • TPST 3
  • BDL 0
  • Target Price
  • TPST $30.00
  • BDL N/A
  • AVG Volume (30 Days)
  • TPST 47.7K
  • BDL 2.4K
  • Earning Date
  • TPST 11-11-2025
  • BDL 08-12-2025
  • Dividend Yield
  • TPST N/A
  • BDL 1.73%
  • EPS Growth
  • TPST N/A
  • BDL 41.91
  • EPS
  • TPST N/A
  • BDL 2.32
  • Revenue
  • TPST N/A
  • BDL $201,851,000.00
  • Revenue This Year
  • TPST N/A
  • BDL N/A
  • Revenue Next Year
  • TPST N/A
  • BDL N/A
  • P/E Ratio
  • TPST N/A
  • BDL $13.70
  • Revenue Growth
  • TPST N/A
  • BDL 8.84
  • 52 Week Low
  • TPST $5.35
  • BDL $22.61
  • 52 Week High
  • TPST $15.73
  • BDL $35.98
  • Technical
  • Relative Strength Index (RSI)
  • TPST 49.98
  • BDL 52.24
  • Support Level
  • TPST $10.09
  • BDL $30.23
  • Resistance Level
  • TPST $10.79
  • BDL $32.90
  • Average True Range (ATR)
  • TPST 0.68
  • BDL 1.11
  • MACD
  • TPST -0.11
  • BDL -0.03
  • Stochastic Oscillator
  • TPST 16.93
  • BDL 60.51

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: